Table 6.

Clinical pathology in both treatment groups

	Dimeticone group n (%)	Permethrin group n (%)	P value
Cervical lymphadenopathy:
Before treatment	49/73 (67.1%)	54/72 (75.0%)	P = 0.3
Day 2	51/73 (69.9%)	52/72 (72.2%)	P = 0.8
Day 4	52/73 (71.2%)	49/72 (68.1%)	P = 0.7
Day 7	39/73 (53.4%)	46/72 (63.9%)	P = 0.2
Day 9	41/72 (56.9%)	45/71 (63.4%)	P = 0.7
Bacterial superinfection of lesions:
Before treatment	1/73 (1.4%)	0/72 (0%)	P = 0.3
Day 2	1/73 (1.4%)	1/72 (1.4%)	P = 1.0
Day 4	1/73 (1.4%)	0/72 (0%)	P = 0.3
Day 7	0/73 (0%)	0/72 (0%)	P = 1.0
Day 9	0/72 (0%)	0/71 (0%)	P = 1.0